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============

An outbreak of extensively drug-resistant (XDR) Salmonella enterica serotype Typhi infections is ongoing in Pakistan ([@B1], [@B2]). Cases have been reported from November 2016 until the present, mostly from Sindh Province in the cities of Karachi and Hyderabad ([@B1], [@B2]). The outbreak strain has been genetically characterized previously, including identification of the resistance determinants and plasmids responsible for the XDR phenotype ([@B2]). Here, we report the sequencing and characterization of five XDR *Salmonella* Typhi isolates from patients in the province of Punjab in 2018.

Five isolates ([Table 1](#tab1){ref-type="table"}) identified as XDR *Salmonella* Typhi at the National Institute of Health in Pakistan were subcultured on blood agar, stored in 40% glycerol Trypticase soy broth, and sent to the U.S. Centers for Disease Control and Prevention. DNA extraction was performed on cultures grown from single-colony frozen stocks on blood agar at 37°C overnight before sequencing on the Illumina MiSeq platform, as previously described ([@B3]). Default parameters were used for all software, unless otherwise specified. Lyve-SET v.1.1.4f ([@B4]) was used for high-quality single nucleotide polymorphism (hqSNP) analysis with an external reference (GenBank accession number [LT882486](https://www.ncbi.nlm.nih.gov/nuccore/LT882486)), using the following options: --min_coverage, 20; --min_alt_frac, 0.95; --allowedFlanking, 5 bp; and --mask-phages. SMALT v.0.7.4 ([@B5]) was used for mapping, and SNPs were called with VarScan v.2.3.7 ([@B6]). *De novo* assemblies generated using shovill v.1.0.4 (<https://github.com/tseemann/shovill>) were analyzed for resistance determinants using the ResFinder database (90% identity, 50% cutoff) and the PointFinder scheme for *Salmonella* spp. implemented in staramr v.0.4.0. Plasmid replicons were identified using abricate v.0.8.10 and a database adapted from PlasmidFinder (90% identity, 60% cutoff). Antibiotic susceptibility testing was performed at the CDC National Antimicrobial Resistance Monitoring System (NARMS) laboratory, using CLSI interpretative criteria ([@B7]). Extracted DNA from one isolate (2018K-0756) from a 29-year-old male resident of Punjab was also sequenced by Pacific Biosciences single-molecule real-time (SMRT) technology. Reads were filtered using RS_Filter from SMRT Analysis v.2.3.0 (minsubreadlength, 1,000) and *de novo* assembled using FLYE v.2.4.2 ([@B8], [@B9]), followed by initial polishing using multiple rounds of Quiver v.2.3.0, and final polishing with Illumina reads using Pilon v.1.22. Annotation of the final assembled chromosome and plasmid was performed using Prokka v.1.13.3 and Galileo AMR ([@B10]) (<http://galileoamr.arcbio.com/mara/>). Additionally, assembly and annotation were performed through the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) upon the submission of reads to GenBank ([@B11]). Alignment of 2018K-0756 to the previously published Sindh Province outbreak strain 22420_1\_10_Pak60006_2016 (GenBank accession number [LT882486](https://www.ncbi.nlm.nih.gov/nuccore/LT882486)) was performed with Mauve in Geneious v.2019.1.1.

###### 

BioSample, GenBank, and SRA accession numbers for sequenced isolates[^*a*^](#ngtab1.1){ref-type="table-fn"}

  Isolate      BioSample accession no.                                                     GenBank accession no.                                                                                                                         SRA accession no.                                                  No. of total reads   Coverage (×)   Plasmid replicon(s)
  ------------ --------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------ -------------------- -------------- ---------------------
  2018K-0753   [SAMN13019481](https://www.ncbi.nlm.nih.gov/biosample/SAMN13019481)         [AALWUW000000000](https://www.ncbi.nlm.nih.gov/nuccore/AALWUW000000000)                                                                       [SRR10267561](https://www.ncbi.nlm.nih.gov/sra/?term=2018K-0753)   759,755              36.8           IncY, ΔIncQ1
  2018K-0754   [SAMN13019479](https://www.ncbi.nlm.nih.gov/biosample/?term=SAMN13019479)   [AALZFY000000000](https://www.ncbi.nlm.nih.gov/nuccore/AALZFY000000000)                                                                       [SRR10267562](https://www.ncbi.nlm.nih.gov/sra/?term=2018K-0754)   1,141,854            56.1           IncY, ΔIncQ1
  2018K-0755   [SAMN13019474](https://www.ncbi.nlm.nih.gov/biosample/?term=SAMN13019474)   [AALZFX000000000](https://www.ncbi.nlm.nih.gov/nuccore/AALZFX000000000)                                                                       [SRR10279247](https://www.ncbi.nlm.nih.gov/sra/?term=2018K-0755)   1,015,738            49.8           IncY, ΔIncQ1
  2018K-0756   [SAMN12774580](https://www.ncbi.nlm.nih.gov/biosample/?term=SAMN12774580)   [CP044007](https://www.ncbi.nlm.nih.gov/nuccore/CP044007) (chromosome), [CP044008](https://www.ncbi.nlm.nih.gov/nuccore/CP044008) (plasmid)   [SRR10279247](https://www.ncbi.nlm.nih.gov/sra/?term=2018K-0756)   1,085,924            53.3           IncY
  2018K-0757   [SAMN13019471](https://www.ncbi.nlm.nih.gov/biosample/?term=SAMN13019471)   [AALWUU000000000](https://www.ncbi.nlm.nih.gov/nuccore/AALWUU000000000)                                                                       [SRR10267564](https://www.ncbi.nlm.nih.gov/sra/SRR10267564)        1,106,063            53.8           IncY, ΔIncQ1
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All five isolates display the same phenotype (ACSSuCxCipNalCot \[A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfisoxazole; Cx, ceftriaxone; Cip, ciprofloxacin; Nal, nalidixic acid; Cot, trimethoprim-sulfamethoxazole\]) and carry the same resistance determinants, namely, *aph(3″)-Ib*, *aph(6)-Id*, *bla*~CTX-M-15~, *bla*~TEM-1B~, *catA1*, *dfrA7*, *qnrS1*, *sul1*, *sul2*, and S83F(*gyrA*).

All isolates were within five pairwise hqSNPs of each other and within five SNPs of 22420_1\_10_Pak60006_2016 according to Pathogen Detection (SNP cluster PDS000002867.370) (<https://www.ncbi.nlm.nih.gov/pathogens/>), confirming their relatedness to the outbreak strain. All had an S83F mutation in the quinolone resistance-determining region of *gyrA* and carried nine resistance genes \[*aph(3″)-Ib*, *aph(6)-Id*, *bla*~CTX-M-15~, *bla*~TEM-1B~, *catA1*, *dfrA7*, *qnrS1*, *sul1*, and *sul2*\]. The XDR phenotype conferred by these resistance determinants was confirmed for all five isolates, namely, resistance to ampicillin, ceftriaxone, chloramphenicol, ciprofloxacin, nalidixic acid, streptomycin, sulfisoxazole, and trimethoprim-sulfamethoxazole. All contained an IncY plasmid replicon and a partial IncQ1 replicon (529 bp of the 796-bp IncQ1 replicon sequence) within the resistance region, except 2018K-0756, which lacked IncQ1. 2018K-0756 carries *catA1*, *dfrA7*, and *sul1* in a chromosomally integrated IS*1*-mediated composite transposon at the same location as in 22420_1\_10_Pak60006_2016 but lacks a 7,857-bp internal region containing the partial IncQ1 replicon, *aph(3″)-Ib*, *aph(6)-Id*, *bla*~TEM-1B~, and *sul2*. The IncY plasmid from 2018K-0756 (p2018K-0756) carries *aph(3″)-Ib*, *aph(6)-Id*, *bla*~CTX-M-15~, *bla*~TEM-1B~, *qnrS1*, and *sul2* and is 99.99% identical (5 SNPs) to that from 22420_1\_10_Pak60006_2016 (p60006) (GenBank accession number [LT906492](https://www.ncbi.nlm.nih.gov/nuccore/LT906492)).

Data availability. {#s1.1}
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The sequences discussed here have been deposited in GenBank and SRA under the accession and BioSample numbers listed in [Table 1](#tab1){ref-type="table"}.
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